Immunization Policy & Financing

Vaccines are an essential public good that governments provide to their citizens. Vaccine costs are rising, often faster than public immunization budgets are expanding. Many countries currently eligible for financial support from Gavi, the Vaccine Alliance, are graduating or will soon graduate from this support. These countries must therefore depend on domestic sources to maintain or improve their immunization programs.

Access & Uptake

Despite scientific advances and international support, 1.5 million people still die each year from diseases that could have been prevented by routine immunization. Sabin works with key decision makers and immunization experts at the country and global level to build resilient, sustainable national immunization programs to reach every child.

Dr. Jan Holmgren Receives 2017 Albert B. Sabin Gold Medal Award

WASHINGTON, D.C. – April 25, 2017 – Tonight, the Sabin Vaccine Institute (Sabin) will honor Dr. Jan Holmgren with the 2017 Albert B. Sabin Gold Medal Award. Dr. Holmgren will be recognized for his pioneering contributions to oral vaccine research and mucosal immunology, as well as his leadership in the discovery of the world's first effective oral cholera vaccine.

Public Health Experts Discuss Vaccines, Antibiotic Resistance and Surveillance at Conference on Typhoid and Other Invasive Salmonelloses

KAMPALA, UGANDA – April 4, 2017 – Today, the Sabin Vaccine Institute opened the 10th International Conference on Typhoid and Other Invasive Salmonelloses in Kampala, Uganda. Over the course of the three day conference, more than 300 experts from around the world have gathered to discuss new typhoid-related research, as well as how to turn this evidence into action in the fight against typhoid.

European Leaders Gather in Georgia for Regional Workshop on Immunization Legislation

TBILISI, GEORGIA — March 1, 2017 — Today, the Sabin Vaccine Institute and the Government of Georgia assembled senior officials from Armenia, Georgia and Moldova to develop legislative roadmaps that will support the sustainability of national immunization programs to protect more than 16.6 million people.

Sabin Vaccine Institute Names Deputy Assistant Secretary for Health as New President of Global Immunization

WASHINGTON, D.C., February 13, 2017 – Sabin Vaccine Institute (Sabin), a non-profit dedicated to making life-improving vaccines more accessible, enabling innovation and expanding immunization across the globe, today announced the appointment of Dr. Bruce Gellin as President, Global Immunization. Dr. Gellin, a 15-year U.S. Department of Health and Human Services (HHS) veteran, has served as Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office since 2002. Among his roles, Dr. Gellin led discussions on behalf of the United States at high-level global and domestic policy advisory groups and was responsible for developing the National Vaccine Plan, our country's blueprint for all aspects of vaccines and immunization.
03.01.17 to 03.02.17
Courtyard Marriott Hotel, Tbilisi, Georgia

The International Association of Immunization Managers Hosts Discussions on Vaccine Confidence During Regional Meeting

Madrid, Spain — February 1, 2017 — Today, the International Association of Immunization Managers (IAIM), based at the Sabin Vaccine Institute (Sabin), began its first-ever regional meeting for members from the Americas and Europe. Immunization experts from around the world have gathered to discuss vaccine acceptance and demand, as well as how to measure vaccine knowledge and perceptions, over the course of the two-day conference.

An estimated two billion people lack the medicines they need. The 2016 Access to Medicines Index analyzes pharmaceutical companies’ efforts to improve access to medicines, vaccines and diagnostics for low- and middle-income countries.

Pages

Subscribe to RSS - Access & Uptake